| L |
|
Laboratory and Clinical Validation of a New Functional, Plasma-Based Assay for the Detection of Factor V Leiden: the Pefakit® APC-R Factor V Leiden Assay
|
| Hoppensteadt D, Cunanan J, Walenga JM, Wilmer M, Janssen M, Kahn S, Fareed J |
| |
|
Laboratory Assessment of von Willebrand Disorder (VWD): Reassessment of ABO-Blood Group, Gender and Age on Laboratory Parameters and the Potential Influence on a Diagnosis of Mild VWD and the Potential Association with Risk of Thrombosis
|
| Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L, Favaloro JWC |
| |
|
Laboratory Identification of Severe Haemophilia Is APTT-Reagent Dependent
|
| Verbruggen HW, Barteling W, van Heerde WL |
| |
|
Laboratory Investigation for Lupus Anticoagulant (LA) Experience of a Large General Hospital
|
| Nokes TJC, Monk S |
| |
|
Laboratory Markers of Cardiovascular Disease in Systemic Lupus Erythematosus: Evidence of a Latent Hypercoagulable State
|
| Hansen HR, Meesters EW, Spronk HMH, van Oerle R, Govers-Riemslag JWP, Hamulyak K, Thomassen S, Rosing J, Rowshani AT, ten Berge IJM, ten Cate H |
| |
|
Laboratory Testing, Diagnosis and Management of Platelet Disorders
|
| Cattaneo M |
| |
|
Lack of Correlation between OD Value of Elisa and Clinical Thrombosis in Patients with Heparin Induced Thrombocytopenia (HIT)
|
| Altuntas F, Matevosyan K, Burner J, Rutherford C, Sarode R |
| |
|
Lack of Occult HBV Infection in Polish Haemophilia Patients
|
| Windyga J, Brojer E, Gronowska A, Grabarczyk K, Mikulska K, Szczepanik AB, Stefanski E |
| |
|
Lack of P-selectin Glycoprotein Ligand-1 Protects Mice from Thrombosis after Thrombotic Challenges
|
| Miszti-Blasius K, Veszpremi A, Xia L, McEver RP, Kappelmayer J |
| |
|
Lactadherin Detects and Blocks Phosphatidylserine in vivo on Stimulated Platelets
|
| Jialan S, Steven WP, Jan TR, Christian WH, Jin Z, Patricia P, Gary EG |
| |
|
Laminin Stimulates Spreading of Platelets Through a6b1-dependent Activation of GPVI
|
| Inoue O, Suzuki-Inoue K, McCarty OJT, Kunicki TJ, Ware J, Ruggeri ZM, Ozaki Y, Watson SP |
| |
|
Large Deletions Explain Protein S Deficiency in Many Cases Where Previous Mutation Detection Has Failed
|
| Johansson AM, Hillarp A, Säll T, Dahlbäck B, Halldén C |
| |
|
Late Prophylaxis for Severe Hemophilia: Effects of Prophylaxis Started in Adulthood
|
| Fischer K, Van Dijk K, Van den Berg HM |
| |
|
Learning of Wistar Rats After Multiple Saline Injections Is a Model of Prethrombosis, Correction with Heparin
|
| Kondashevskaya MV |
| |
|
Lentiviral Vector-Mediated A20 Gene Transfer to Generate Endothelial (Progenitor) Cells that are Resistant to Inflammatory Stimuli
|
| Liu JW, Dignat-George F, Sabatier F, Bounameaux H, Kruithof EKO |
| |
|
Lentivirus Destruction and DC-SIGN Expression by Platelets and Megakaryocytes
|
| Boukour S, Massé JM, Bénit L, Dubart-Kupperschmitt A, Cramer EM |
| |
|
Lessons from Clinical Trials – Appropriate Outcomes
|
| Bounameaux H |
| |
|
Leukemia after P32 Radionuclide Synovectomy for Hemophilic Arthropathy
|
| Dunn A, Manco-Johnson M, Balark K, Abshire T |
| |
|
Leukocyte Activation in Myeloproliferative Disease
|
| Maugeri N, Giordano G, Petrilli MP, Cerletti C, de Gaetano G, Storti S, Donati MB |
| |
|
Limited Antiplatelet Effect of Clopidogrel In Aspirin-treated Patients with Coronary Artery Disease Associates with Cardiac Endpoints
|
| Lepäntalo A, Virtanen KS, Lassila R |
| |
|
Linear and Cyclic RGD Peptides Containing Salicylic Acid Derivatives and Their Antiplatelet Activity In Vitro
|
| Sarigiannis Y, Stavropoulos G, Liakopoulou-Kyriakides M, Pithara E, Ioannidis G, Girtovitis F, Spartali A, Makris PE |
| |
|
Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study
|
| Eikenboom J, Van Marion V, Putter H, Peake I, Goodeve A, Rodeghiero F, Castaman G, Federici A, Batlle J, Meyer D, Mazurier C, Goudemand J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, Hill F |
| |
|
Linkage Analysis Reveals No Evidence for Loci Other than the Factor VII Gene Influencing Factor VII Levels
|
| Vossen CY, Hasstedt SJ, Rosendaal FR, Long GL, Scott BT, Callas PW, Bovill EG |
| |
|
Lipid Peroxidation as a Determinant of Platelet Activation in Hypertensives with Microalbuminuria
|
| Falco A, Ferroni P, Guagnano MT, Paoletti V, Manigrasso MR, Pescara L, Michetti N, Ciabattoni G, Patrono C, Davì G |
| |
|
Lipid Rafts Facilitate the Interaction of PECAM-1 with the GPVI-FcRg Complex in Human Platelets
|
| Lee F, Farndale W |
| |
|
Lipopolysaccharide-Induced Endotoxemia in the Mouse is Aggravated by PAI-1 Overexpression
|
| Poggi M, Paulmyer-Lacroix O, Bastelica D, Frere C, Verdier M, Lijnen HR, Juhan-Vague I, Alessi MC |
| |
|
Lipopolysaccharide-induced Monocyte Procoagulant Activity – Discrepancy Between Tissue Factor Activity and Tissue Factor Expression May Reside in Increased Phosphatidylserine Exposure Due to Cell Death
|
| Henriksson CE, Klingenberg O, Øvstebø R, Joø GB, Westvik, ÅB, Kierulf P |
| |
|
Lipoprotein Pattern in Patients with Retinal Artery Occlusion or Retinal Vein Occlusion
|
| Stojakovic T, Scharnagl H, Weger M, Schmut O, Haas A, März W |
| |
|
Living with Morbus Glanzmann – A Case Report of a Now 20 Year Old Mother
|
| Topf HG, Groeschl M, Rauh M, Lischetzki G |
| |
|
LMWH-Induced Thrombocytopenia (Type II) Successfully Treated with Fondaparinux (Arixtra®)
|
| D'Angelo A, Crippa L, Della Valle P, Fattorini A, Vigano' D'Angelo S |
| |
|
Local Attenuation of the Protein C Pathway in Patients Developing Pneumonia
|
| Choi G, Millo JL, Levi M, van der Poll T, Garrard CS, Schultz MJ |
| |
|
Localization of Factor Va and Factor Xa Binding to Lipid Rafts in Human Platelets
|
| Gould WR, Thaisrivongs DA, Leadley Jr RJ |
| |
|
Long Term and Low Dose Prophylaxis with rFVIIa in Patients Affected by Congenital Bleeding Disorders
|
| Morfini M, Linari S, Paladino E, Cinotti S |
| |
|
Long Term Prophylaxis of Bleeding Episodes in Patients with von Willebrand Disease: Efficacy and Safety of Factor VIII/von Willebrand Factor Concentrates
|
| Federici AB, Gianniello F, Mannucci PM |
| |
|
Long Term Storage and Stability of Urinary 11-Dehydro Thromboxane B2
|
| Wentworth S, Lauzon M, Johnston M |
| |
|
Long-Haul Flights Do Not Activate Haemostasis in Young Healthy Men
|
| Boneu B, Emmerich J, Thalamas C, Lane D, Ruidavets JB, Boccalon H |
| |
|
Long-Term Clinical Experience with FEIBA VH in Hemophilia Patients with Inhibitors
|
| Saxena K, Hawk S, Stevens B, Sexauer C |
| |
|
Long-Term Occurrence of Venous Thromboembolism after Major Joint Surgery
|
| Bjørnarå BT, Gudmundsen TE, Dahl OE |
| |
|
Long-Term Outcomes after Deep-Vein Thrombosis in Asia. The AIDA-Extension Study
|
| Piovella F, Wang CJ, Lee LH, Lee WC, Turpie AG, Gallus A, Planes A, Passera R, the AIDA Investigators |
| |
|
Long-term Prophylaxis in VWD. The Swedish Experience
|
| Berntorp E, Baghaei F, Holmström M, Lethagen S, Stigendal L, Petrini P |
| |
|
Long-Term Safety and Efficacy Data on Neonatal Thromboembolism Treated with Dalteparin or Enoxaparin: A Comparison of Once Daily Versus Twice Daily Administration
|
| Bidligmaier C, Düring C, Schobess R, Kurnik K, Merkel N, Nowak-Göttl U |
| |
|
Long-Term Treatment with High-Dose Recombinant Human Antithrombin does not Prevent Acute Humoral Rejection in Primate Recipients of Porcine Xenografts
|
| Simioni P, Cozzi E, Boldrin M, Calabrese F, Gavasso S, Seveso M, Tognin G, Baldan N, Echelard Y, Rice T, Thiene G, Pagnan A, Ancona E |
| |
|
Loss of GATA-1 and Gain of FLI-1 Expression During Thrombocyte Maturation in Zebrafish
|
| Pudur J |
| |
|
Loss of Gs Activity in Platelets from Carriers with a Heterozygous Missense Mutation in the Regulator of G-protein Signaling 2 (RGS2)
|
| Freson K, Jaeken J, Wittevrongel C, Thys C, Vermylen J, Van Geet C |
| |
|
Loss of Terminal Fucose Expression in Bombay Phenotype Produces Reduced Plasma VWF Level Through a Conformation-Related Increased Susceptibility to ADAMTS-13
|
| McKinnon TAJ, Laffan MA, RiddellO'Donnell AFJS |
| |
|
Low Amounts Of rVIIa Are Sufficient to Trigger Initiation of Thrombin Generation in Factor VII Deficient Patients
|
| Mathijssen NCJ, Lap PAJ, Loof AH, Masereeuw R, Verbruggen HW, van Kraaij mgJ, Nováková IRO, van Heerde WL |
| |
|
Low CD4/CD8 Ratios In HIV Negative Haemophilia Patients Cause High HCV Viraemia
|
| Meijer K, Kalk S, Smid WM, Van der Meer J |
| |
|
Low Dose (<60 mcg/kg) Recombinant Factor VIIa in Trauma or Coagulopathy
|
| Dager W, Regalia R, Williamson D, King J, Gosselin R, White R, Tharratt S, Albertson T, Owings J |
| |
|
Low Dose-beneficial Effects of Acetylsalicylic Acid (ASA) Modify Fibrinogen Clotting Property in a Purified System Leading to Increase of the Fibrin Gel Porosity
|
| He S, Blombäck M |
| |
|
Low Heparin (Dalteparin) as a New Treatment for Ophthalmological Arterial-Venous Vessels Occlusion
|
| Halimeh S, Rott H, Trobisch H |
| |
|
Low Methionine Concentration as a Risk Factor for Recurrent Venous Thrombosis
|
| Keijzer M, den Heijer M, Borm G, Blom HJ, Vollset SE, Hermus AR, Ueland PM |
| |
|
Low Molecular Weight Fucoidan Is More Effective Than Low Molecular Weight Heparin in Preventing Arterial Thrombosis in a Rabbit Model
|
| Helley D, Durand E, Dujols C, Al Hajzen A, Bruneval P, Colliec-Jouault S, Lafont A, Fischer AM |
| |
|
Low Molecular Weight Fucoidan Potentiates the Growth Factor-Induced Tube Formation By Endothelial Progenitor Cells
|
| Zemani F, Benisvy D, Galy-Fauroux I, Lokajczyk A, Colliec-Jouault S, Fischer AM, Boisson-Vidal C |
| |
|
Low Molecular Weight Heparin (LMWH) Therapy in Neonates and Children with Venous Thromboembolism (VTE)
|
| Bonduel M, Hepner M, Sciuccati G, Feliú A, Pieroni G, Frontroth JP |
| |
|
Low Molecular Weight Heparin Attenuates Multiorgan Failure in DIC
|
| Slofstra S, van't Veer C, Buurman W, Reitsma P, ten Cate H, Spek C |
| |
|
Low Molecular Weight Heparin for Venous Thromboembolism Prophylaxis in Elective Colorectal Surgery
|
| Riffat F, Ctercteko G, Fletcher J |
| |
|
Low Plasma Levels of Vitamin B6 and Recurrent Venous Thrombosis: Risk Assessment and Effect of Combined Vitamin Supplementation in the VITRO-Trial
|
| Cattaneo M, Lombardi R, Lecchi A, Bos G, Blom H, Rosendaal F, den Heijer M |
| |
|
Low Platelet Response to Clopidogrel Increased the Risk of Recurrent Atherothrombotic Events in Patients with Non-ST Acute Coronary Syndrome after Coronary Stenting
|
| Frere C, Quilici J, Cuisset T, Morange PE, Bonnet JL, Juhan-Vague I, Alessi MC |
| |
|
Low Protein Z Levels and Venous Thrombosis
|
| Razzari C, Martinelli I, Biguzzi E, Bucciarelli P, Mannucci PM |
| |
|
Low rate of Responsiveness to Aspirin in Acute Brain Ischemia: Association with Stroke Severity and Clinical Outcome
|
| Schwammenthal Y, Tsabari R, Matetzky S, Lubetsky A, Shenkman B, Orion D, Chapman J, Savion N, Varon D, Tanne D |
| |
|
Low-Dose Aspirin for Secondary Prophylaxis of Vein Thrombosis – A Prospectively Planned Meta-Analysis
|
| Brighton TA, Eikelboom JW, Gallus A, Ockelford P, Becattini C, Agnelli G, Simes RJ |
| |
|
Low-Molecular-Weight Heparin or Unfractionated Heparin as Bridging Therapy in Patients on Long-term Oral Anticoagulants: Results from the REGIMEN Registry
|
| Spyropoulos AC, Turpie AGG, Dunn AS, Spandorfer J, Douketis J, Jacobson A, Frost FJ |
| |
|
Low-Molecular-Weight Heparins for Prophylaxis and Treatment of Venous Thromboembolism in Pregnancy: A Systematic Review of Safety and Efficacy
|
| Greer IA, Nelson-Piercy C |
| |
|
Lung-Protective Mechanical Ventilation Attenuates Fibrin Generation in Healthy Lungs
|
| Choi G, Wolthuis EK, Bresser P, Levi M, van der Poll T, Dzoljic M, Vroom M, Schultz MJ |
| |
|
Lupus Anticoagulant (LA) is Significantly Associated with Inflammation Among Patients Suspected for Deep Vein Thrombosis (DVT)
|
| Sidelmann JJ, Sjøland JA, Bertelsen V, Münster H, Mourits-Andersen T, Münster AMB |
| |
|
Lupus Anticoagulant and FV Leiden Associated with Clozapine Use and Venous Thromboembolism
|
| Maly R, Masopust J, Konupcikova K, Urban A, Dulicek P |
| |
|
Lupus Anticoagulant Interferes with Detection of Heparin Levels in Plasma
|
| Urbanus RT, de Groot PG, Derksen RHWM |
| |
|
Lupus Anticoagulant Testing Using a Dilute Prothrombin Time with Confirm Procedure
|
| Lawrie AS, Mackie IJ, Purdy G, Greenfield RS, Guinto ER, Machin SJ |
| |
|
Lupus Anticoagulants IgG with or without Anti-b2-Glycoprotein I Induced Acquired Activated Protein C Resistance Evidenced by Calibrated Automated Thrombography
|
| Wahl D, Regnault V, Perret-Guillaume C, Kaminsky P, Hemker HC, Lecompte T |
| |
|
Lymphocyte-Platelet Adhesion in Children with Chronic Gastritis
|
| Shcherbak VA |
| |
